Gastric Cancer

Screening for Gastric Cancer - Gastric Cancer Screening

Information We Collect In this section of our Privacy Policy, we discuss the different types of information that we may collect about you, and the ways in which such information may be collected. Information We Collect from Unregistered Visitors You must register to access all of the Services, however, you may be able to access certain limited areas of the Services without disclosing any personally identifiable information. We collect non-personally identifiable information (i.e., information that is not traced back to any individual and is not used on its own to identify an individual) about your use of the Services through the use of cookies, even if you have not registered, including the referring website, if applicable, the type of browser you use, and the time and date that you accessed the Services. The section of this Privacy Policy entitled "Cookies and Web Beacons," below, further describes how we use cookies and how you can limit our use of cookies. Information We Collect When You Register When you register for the Services, you are asked to provide identifying information such as your name, e-mail address, zip code, and other professional information (e.g., specialty). We may use your registration information to send you communications by e-mail about our products and services and the products and services of our third party sponsors. By registering for the Services, you are consenting to receive these communications. You may also subscribe to receive certain e-mail newsletters sent to registered users from time to time which you may manage through the newsletter subscriptions area within your account settings. If you are required to provide additional personally identifiable information to access a particular component of the Services, or if we would like to use personally identifiable information that you have previously provided in a manner not otherwise permitted under this Privacy Policy, we will explain how we intend to use such personally identifiable information at the time of collection and will require your consent at that time to any such collection and use. Continuing Medical Education When you participate in a Continuing Medical Education (CME) or a Continuing Education (CE) activity through the Services, you may be asked to provide personally identifiable information such as your name and mailing address. helpful site

Members of Congress Ask National Cancer Institute to Raise Profile of Gastric Cancer Research

The major type of gastric cancer is adenocarcinoma, or cancer of the glandular tissue in the stomach. Other rarer forms of stomach cancer include lymphomas (cancer involving the lymphatic system) and sarcomas (cancer of the connective tissue, such as muscle, fat, or blood vessels). Risk of gastric cancer Gastric cancer is the fourteenth leading cause of cancer deaths in the United States. Although the incidence of stomach cancer in the United States has decreased since the 1930s, gastric cancer is a major cause of death worldwide, especially in developing countries. Anything that increases a persons chance of developing a disease is called a risk factor. Some of these risk factors for gastric cancer are as follows: PRE-EXISTING CONDITIONS: If you already have one of the following conditions, you may have a higher-than-average risk of developing stomach cancer: chronic gastritis, intestinal metaplasia, pernicious anemia, gastric polyps, or Helicobacter pylori infection of the stomach. OLDER AGE: Two out of every three people diagnosed with gastric cancer are older than 66 years of age. FAMILY HISTORY: If you have a mother, father, brother, or sister who has had stomach cancer, you may have a higher-than-average risk of developing gastric cancer. DIET AND LIFESTYLE: If you smoke cigarettes and eat many salted, smoked, or poorly preserved foods but few fruits and vegetables, you may have a higher-than-average risk of developing gastric cancer. See All Stomach Cancer Topics web url

The overall five-year relative survival rate for people with gastric cancer in the United States is about 27 percent. At Stage IV, the five-year survival rate is four percent. These statistics offer a compelling case for why more funding is needed for gastric cancer. Currently, gastric cancer receives by far the lowest amount of research funding for the common cancers at NCI, at only $12 million in 2012, or 0.4 percent of NCI-funded research. The Senate letter complements a letter sent to the NCI in July by members of the U.S. House of Representatives. That letter was led by Reps. Peter Roskam (R-IL) and Debbie Wasserman-Schultz (D-FL) and signed by 37 other representatives. "These letters constitute critical steps toward reaching our goal of increased federal funding for gastric cancer research," said DDF President and Founder Debbie Zelman. "Debbie's Dream Foundation: Curing Stomach Cancer is thrilled and honored to have the support of members of Congress who share our concerns about the state of gastric cancer research in this country," said Kristin Fitzgerald, Chair of DDF's Advocacy Committee. "Gastric cancer is one of 20 cancers being studied under The Cancer Genome Atlas (TCGA), but without more funding for gastric cancer research, the promise of the TCGA will go unfulfilled." On May 20, 2013 DDF held its first Capitol Hill Stomach Cancer Advocacy Day in Washington, DC. DDF advocates, including gastric cancer patients, caregivers and physicians, from 16 states traveled to Capitol Hill to share personal experiences with gastric cancer and to advocate for more research dedicated to this deadly disease. pop over to this website